1. Viral and H1N1 Infections – Pipeline Review,
H1 2013
Viral Infection and H1N1 Infection are 2 different report studies by Global Markets Direct. It provides an
overview of the indication’s therapeutic pipeline. These reports provide information on the therapeutic
development for Viral and H1N1 Infection, complete with latest updates, and special features on late-
stage and discontinued projects. It also reviews key players involved in the therapeutic development for
Viral and H1N1 Infection.
Scope
- A snapshot of the global therapeutic scenario for Viral and H1N1.
- A review of the Viral and H1N1products under development by companies and universities/research
institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration
stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Viral and H1N1 Infection pipeline on the basis of route of administration and molecule
type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Viral and
H1N1Infection.
- Identify emerging players with potentially strong product portfolio and design effective counter-
strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Viral and H1N1 Infection pipeline
depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with
the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors
that drove them from pipeline.
Check out complete Viral Infection Pipeline review @
http://www.reportsnreports.com/reports/228413-viral-infections-pipeline-
review-h1-2013.html
Get a copy of H1N1 Infection Pipeline review market with comprehensive Table of Contents @
http://www.reportsnreports.com/reports/228412-h1n1-infection-pipeline-
review-h1-2013.html

2. Report Details:
Published: March 2013
Price: Single User License: US$2000 Corporate User License: US$ 6000
Table of Contents:
List of Figures - H1N1 Infection – Pipeline Review, H1 2013
Number of Products under Development for H1N1 Infection, H1 2013 14
Products under Development for H1N1 Infection – Comparative Analysis, H1 2013 15
Products under Development by Companies, H1 2013 16
Products under Investigation by Universities/Institutes, H1 2013 20
Late Stage Products, H1 2013 21
Mid Clinical Stage Products, H1 2013 22
Early Clinical Stage Products, H1 2013 23
Discovery and Pre-Clinical Stage Products, H1 2013 24
Assessment by Monotherapy Products, H1 2013 66
Assessment by Combination Products, H1 2013 67
Assessment by Route of Administration, H1 2013 68
Assessment by Stage and Route of Administration, H1 2013 69
Assessment by Molecule Type, H1 2013 70
Assessment by Stage and Molecule Type, H1 2013 71
List of Figures - Viral Infections – Pipeline Review, H1 2013
Number of Products under Development for Viral Infections, H1 2013 33
Products under Development for Viral Infections – Comparative Analysis, H1 2013 34
Products under Development by Companies, H1 2013 35
Products under Investigation by Universities/Institutes, H1 2013 58
Late Stage Products, H1 2013 63
Mid Clinical Stage Products, H1 2013 64
Early Clinical Stage Products, H1 2013 65
Discovery and Pre-Clinical Stage Products, H1 2013 66
Assessment by Monotherapy Products, H1 2013 372
Assessment by Combination Products, H1 2013 373
Assessment by Route of Administration, H1 2013 374
Assessment by Stage and Route of Administration, H1 2013 375
Assessment by Molecule Type, H1 2013 377
Assessment by Stage and Molecule Type, H1 2013 378
Contact sales@reportsandreports.com for further information.